ACB
Aurora CannabisACB
ACB
About: Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.
Employees: 1,130
0
Funds holding %
of 7,398 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
147% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 15
84% more call options, than puts
Call options by funds: $32.3M | Put options by funds: $17.6M
13% more funds holding
Funds holding: 144 [Q3] → 162 (+18) [Q4]
2.3% more ownership
Funds ownership: 6.58% [Q3] → 8.89% (+2.3%) [Q4]
2% less capital invested
Capital invested by funds: $21.2M [Q3] → $20.7M (-$429K) [Q4]
10% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 29
Research analyst outlook
We haven’t received any recent analyst ratings for ACB.
Financial journalist opinion
Based on 11 articles about ACB published over the past 30 days
Neutral
PRNewsWire
1 day ago
Aurora Cannabis Recognized for Executive Gender Diversity by The Globe and Mail
Canada's Largest Medical Cannabis Company is an Honouree in The Globe and Mail's 2025 Report on Business Magazine's sixth annual Women Lead Here List EDMONTON, AB , March 31, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has been named an honouree on the Globe & Mail's 2025 Report on Business, Women Lead Here list. This annual editorial benchmark recognizes the top publicly traded Canadian companies with the highest gender diversity at the executive level.
Positive
MarijuanaStocks
2 days ago
Top Canadian Cannabis Stocks to Watch in April 2025
Top Canadian cannabis stocks are attracting attention this week as investors seek opportunities in a rapidly evolving industry. Companies like Cronos Group, SNDL Inc., and Aurora Cannabis continue strengthening their positions in Canadian and international markets. Though based in Canada, these firms have exposure to the U.S. through strategic investments and partnerships. The U.S. cannabis industry is expected to generate over $45 billion annually by 2025. Legalization efforts are expanding, and several states are reviewing new adult-use and medical cannabis bills. At the same time, court rulings and state-level decisions continue to shape the legal landscape. Because of this, Canadian companies with U.S. exposure are drawing increased interest from traders and long-term investors alike.
Neutral
GlobeNewsWire
4 days ago
Ethos Cannabis Expands Pennsylvania Presence with Aurora Launch and Title Sponsorship at the Pennsylvania Cannabis Convention
MSO Unveils Premium Infused Live Resin Flower and Leads Industry Conversations at Pennsylvania Cannabis Convention MSO Unveils Premium Infused Live Resin Flower and Leads Industry Conversations at Pennsylvania Cannabis Convention
Neutral
PRNewsWire
6 days ago
Aurora Cannabis to Speak at the Global Cannabis Regulatory Summit
NASDAQ | TSX: ACB Canada's Largest Medical Cannabis Company to Participate as an Industry Leader in the Inaugural Regulatory Event in Washington, D.C. EDMONTON, AB , March 25, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to be attending, sponsoring and speaking at the 2025 Global Cannabis Regulatory Summit (GCRS), held within the U.S. Capitol Complex in Washington, D.C.
Neutral
PRNewsWire
1 week ago
Aurora Cannabis Announces Breakthrough Discovery of Powdery Mildew Resistant Cultivars
NASDAQ | TSX: ACB Groundbreaking research at Aurora Coast, Aurora's world-class research and development facility, sets new standard in cannabis science EDMONTON, AB , March 20, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the Company's discovery of a novel source of genetic resistance against powdery mildew, PM2, that provides strong protection against this pathogen in cannabis sativa. The development of this proprietary genetic marker technology, which is now in use in Aurora's breeding program, is set to produce powdery mildew resistant cultivars that will be explored for commercial launch this year.
Neutral
MarijuanaStocks
1 week ago
3 Canadian Marijuana Stocks To Watch For Future Gains 2025
Marijuana stocks have been facing a downward trend in the market for some time. A big reason is regulatory uncertainty and reform issues. Legislative changes, particularly in major markets like the U.S., can greatly affect how shareholders think. Additionally, oversupply in certain regions has led to falling prices, which negatively affects revenue for companies in the sector. This has created a volatile sector where the trading behavior of the most public companies is more on the low end.
Positive
Zacks Investment Research
2 weeks ago
Aurora Cannabis Rides the Global Legalization Wave: Should You Invest?
ACB capitalizes on the rapidly evolving medical cannabis landscape, leveraging its EU GMP-certified manufacturing facilities, advanced genetics and deep regulatory knowledge.
Negative
Zacks Investment Research
2 weeks ago
Are Medical Stocks Lagging Aurora Cannabis (ACB) This Year?
Here is how Aurora Cannabis Inc. (ACB) and Concentra Group (CON) have performed compared to their sector so far this year.
Positive
MarijuanaStocks
2 weeks ago
High-Potential Canadian Cannabis Stocks to Watch This Month
The Canadian cannabis sector remains a key player in the global market. Many top Canadian companies are expanding into the U.S. in anticipation of future federal legalization. The U.S. cannabis industry continues to grow rapidly, with sales expected to surpass $40 billion in 2025. More states are legalizing cannabis, increasing market opportunities for Canadian producers. Recently, lawmakers introduced new federal reform bills that could ease banking restrictions and boost industry expansion. Investors are closely watching these developments as they could impact stock performance. With growing demand and regulatory progress, top Canadian cannabis stocks remain attractive.
Positive
MarijuanaStocks
3 weeks ago
Investing in Cannabis: Best Canadian Stocks to Watch in March 2025
The Canadian cannabis sector continues to evolve as companies expand operations and navigate industry challenges. Many Canadian cannabis producers are looking beyond their domestic market and establishing strong positions in the U.S. Despite federal restrictions. Some have developed partnerships, investments, or business strategies that position them well for eventual legalization.
Charts implemented using Lightweight Charts™